In a longitudinal clinical study to compare two groups, the primary end point is often the time to a specific event (eg, disease progression, death). The hazard ratio estimate is routinely used to ...

BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall survival (OS) in high-risk early breast cancer, data reported here showed.

2023 MAY 17 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Data detailed on Oncology - Liver Cancer have been presented. According to news reporting originating from ...

Background Although voting is recognised as a social determinant of health, the association between electoral participation ...

Show More Hajime Uno, Deborah Schrag, and Susanna Jacobus, Dana-Farber Cancer Institute; Brian Claggett, Hicham Skali, and Scott Solomon, Harvard Medical School, Brigham and Women's Hospital; Michael ...